Comment on

• Malignancies associated with tumour necrosis factor inhibitors in registries and prospective observational studies: a systematic review and meta-analysis.

  Mariette X, Matucci-Cerinic M, Pavelka K, Taylor P, van Vollenhoven R, Heatley R, Walsh C, Lawson R, Reynolds A, Emery P. Mariette X, et al. Ann Rheum Dis. 2011 Nov;70(11):1895-904. doi: 10.1136/ard.2010.149419. Epub 2011 Sep 1. Ann Rheum Dis. 2011. PMID: 21885875
• A randomized controlled trial of rituximab following failure of antiviral therapy for hepatitis C virus-associated cryoglobulinemic vasculitis.

  Sneller MC, Hu Z, Langford CA. Sneller MC, et al. Arthritis Rheum. 2012 Mar;64(3):835-42. doi: 10.1002/art.34322. Arthritis Rheum. 2012. PMID: 22147444 Free PMC article. Clinical Trial.
• A randomized controlled trial of rituximab for the treatment of severe cryoglobulinemic vasculitis.

  De Vita S, Quartuccio L, Isola M, Mazzaro C, Scaini P, Lenzi M, Campanini M, Naclerio C, Tavoni A, Pietrogrande M, Ferri C, Mascia MT, Masolini P, Zabotti A, Maset M, Roccatello D, Zignego AL, Pioltelli P, Gabrielli A, Filippini D, Perrella O, Migliaresi S, Galli M, Bombardieri S, Monti G. De Vita S, et al. Arthritis Rheum. 2012 Mar;64(3):843-53. doi: 10.1002/art.34331. Arthritis Rheum. 2012. PMID: 22147661 Clinical Trial.
• American College of Rheumatology 2012 recommendations for the use of nonpharmacologic and pharmacologic therapies in osteoarthritis of the hand, hip, and knee.

  Hochberg MC, Altman RD, April KT, Benkhalti M, Guyatt G, McGowan J, Towheed T, Welch V, Wells G, Tugwell P; American College of Rheumatology. Hochberg MC, et al. Arthritis Care Res (Hoboken). 2012 Apr;64(4):465-74. doi: 10.1002/acr.21596. Arthritis Care Res (Hoboken). 2012. PMID: 22563589 Review.
• Use of serum procalcitonin to detect bacterial infection in patients with autoimmune diseases: a systematic review and meta-analysis.

  Wu JY, Lee SH, Shen CJ, Hsieh YC, Yo PH, Cheng HY, Chan RC, Lee CC, Chang SS. Wu JY, et al. Arthritis Rheum. 2012 Sep;64(9):3034-42. doi: 10.1002/art.34512. Arthritis Rheum. 2012. PMID: 22605405
• Placebo-controlled trial of tofacitinib monotherapy in rheumatoid arthritis.

  Fleischmann R, Kremer J, Cush J, Schulze-Koops H, Connell CA, Bradley JD, Gruben D, Wallenstein GV, Zwillich SH, Kanik KS; ORAL Solo Investigators. Fleischmann R, et al. N Engl J Med. 2012 Aug 9;367(6):495-507. doi: 10.1056/NEJMoa1109071. N Engl J Med. 2012. PMID: 22873530 Clinical Trial.
• Tofacitinib or adalimumab versus placebo in rheumatoid arthritis.

  van Vollenhoven RF, Fleischmann R, Cohen S, Lee EB, García Meijide JA, Wagner S, Forejtova S, Zwillich SH, Gruben D, Koncz T, Wallenstein GV, Krishnaswami S, Bradley JD, Wilkinson B; ORAL Standard Investigators. van Vollenhoven RF, et al. N Engl J Med. 2012 Aug 9;367(6):508-19. doi: 10.1056/NEJMoa1112072. N Engl J Med. 2012. PMID: 22873531 Clinical Trial.
• Long-term cardiovascular risk of nonsteroidal anti-inflammatory drug use according to time passed after first-time myocardial infarction: a nationwide cohort study.

  Olsen AM, Fosbøl EL, Lindhardsen J, Folke F, Charlot M, Selmer C, Bjerring Olesen J, Lamberts M, Ruwald MH, Køber L, Hansen PR, Torp-Pedersen C, Gislason GH. Olsen AM, et al. Circulation. 2012 Oct 16;126(16):1955-63. doi: 10.1161/CIRCULATIONAHA.112.112607. Epub 2012 Sep 10. Circulation. 2012. PMID: 22965337
• 2012 American College of Rheumatology guidelines for management of gout. Part 1: systematic nonpharmacologic and pharmacologic therapeutic approaches to hyperuricemia.

  Khanna D, Fitzgerald JD, Khanna PP, Bae S, Singh MK, Neogi T, Pillinger MH, Merill J, Lee S, Prakash S, Kaldas M, Gogia M, Perez-Ruiz F, Taylor W, Lioté F, Choi H, Singh JA, Dalbeth N, Kaplan S, Niyyar V, Jones D, Yarows SA, Roessler B, Kerr G, King C, Levy G, Furst DE, Edwards NL, Mandell B, Schumacher HR, Robbins M, Wenger N, Terkeltaub R; American College of Rheumatology. Khanna D, et al. Arthritis Care Res (Hoboken). 2012 Oct;64(10):1431-46. doi: 10.1002/acr.21772. Arthritis Care Res (Hoboken). 2012. PMID: 23024028 Free PMC article. No abstract available.
• 2012 American College of Rheumatology guidelines for management of gout. Part 2: therapy and antiinflammatory prophylaxis of acute gouty arthritis.

  Khanna D, Khanna PP, Fitzgerald JD, Singh MK, Bae S, Neogi T, Pillinger MH, Merill J, Lee S, Prakash S, Kaldas M, Gogia M, Perez-Ruiz F, Taylor W, Lioté F, Choi H, Singh JA, Dalbeth N, Kaplan S, Niyyar V, Jones D, Yarows SA, Roessler B, Kerr G, King C, Levy G, Furst DE, Edwards NL, Mandell B, Schumacher HR, Robbins M, Wenger N, Terkeltaub R; American College of Rheumatology. Khanna D, et al. Arthritis Care Res (Hoboken). 2012 Oct;64(10):1447-61. doi: 10.1002/acr.21773. Arthritis Care Res (Hoboken). 2012. PMID: 23024029 Free PMC article. No abstract available.